Swiss National Bank Monte Rosa Therapeutics, Inc. Transaction History

Swiss National Bank

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Aug 09, 2023	BUY	$4.53 - $8.4 $224,235 - $415,800	49,500 Added 118.42%	91,300 $625,000
Q1 2023 May 10, 2023	SELL	$5.95 - $8.21 $12,495 - $17,241	-2,100 Reduced 4.78%	41,800 $325,000
Q2 2022 Aug 09, 2022	BUY	$6.15 - $14.99 $100,860 - $245,836	16,400 Added 59.64%	43,900 $425,000
Q1 2022 May 09, 2022	BUY	$10.36 - $20.41 $19,684 - $38,779	1,900 Added 7.42%	27,500 $386,000
Q4 2021 Feb 08, 2022	BUY	$16.28 - $27.15 $416,768 - $695,040	25,600 New	25,600 $523,000

43.9M

141K

31.2K

Ticker GLUE
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 46,713,900
Market Cap $426M
Description
Monte Rosa Therapeutics, Inc., a biopharmaceutical company, engages in the development of novel small molecule precision medicines that employ the body's natural mechanisms to selectively degrade therapeutically relevant proteins. It develops an oral molecular glue degrader for GSPT1, a translational termination factor and degron-containing prot...

Get notified when there are updates to the investment portfolio of Swiss National Bank, based on Form 13F filings with the SEC.

Stay updated on Swiss National Bank with notifications on news.